Ancora.ai AG

Ancora.ai is an AI-powered platform that supports clinical trials with powerful and patient-friendly technology.

We have three customers: 2 Pharma and 1 CRO. We have a CRO, a Pharma, and several hospitals in our pipeline. We have several partnerships also in place (hospital tech company, e-consent company).

We are the technical backbone for the future of remote clinical trials. Trial sites, CROs and Pharma running trials can use Ancora.ai to provide one seamless experience to patients throughout their participation. Value for CROs/Pharma is patient engagement and for hospitals Ancora.ai helps save time and ensure that trials become part of everyday practice for the first time.

Patients and physicians struggle with participating in clinical research and with the pandemic stoking fire of digitization in healthcare, clinical trials MUST offer more remote and decentralized services to continue. Ancora.ai is the platform that connects patients and clinicians to trials.

www.ancora.ai or https://www.youtube.com/watch?v=lcDaY7LxKaM&t=10s for product demo.

Companies in similar space include Antidote, Clara Health, Medable.

Our AI algorithms are proprietary and have taken 3 years to develop. Off-the-shelf ontologies are not useful in the complex world of clinical trials and when providing a patient-friendly experience. We use NLP as the translator to connect patients to clinical research.

CRO - subscription/trial
Hospitals / sites: subscription/trial
Patients -users, free
Physicians - users, free
Pharma (subscripton/per trial)

B2B

Key hires. Integration of partner offerings. B2B customer development. Localization in Europe.

We aim to raise a seed round of 2M USD.

Google Female Founders, EIT Health Headstart, Almirall Digital Garden, Future Perfect, Digital Top 50.

See above.